Koa Shoji Holdings Co.,Ltd. (9273.T)
JPY 648.0
(1.09%)
JPY 648.0
(1.09%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 22.13 Billion JPY | 0.37% |
| 2022 | 22.05 Billion JPY | 8.35% |
| 2021 | 20.35 Billion JPY | 14.24% |
| 2020 | 17.81 Billion JPY | 11.11% |
| 2019 | 16.03 Billion JPY | 5.45% |
| 2018 | 15.2 Billion JPY | 2.57% |
| 2017 | 14.82 Billion JPY | -2.04% |
| 2016 | 15.13 Billion JPY | -0.63% |
| 2015 | 15.22 Billion JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 Q3 | 5.38 Billion JPY | -3.06% |
| 2023 Q4 | 5.36 Billion JPY | -0.52% |
| 2023 Q1 | 5.82 Billion JPY | -1.2% |
| 2023 FY | 22.13 Billion JPY | 0.37% |
| 2023 Q2 | 5.55 Billion JPY | -4.52% |
| 2022 Q4 | 5.89 Billion JPY | 18.06% |
| 2022 FY | 22.05 Billion JPY | 8.35% |
| 2022 Q1 | 5.35 Billion JPY | 0.78% |
| 2022 Q2 | 5.8 Billion JPY | 8.39% |
| 2022 Q3 | 4.99 Billion JPY | -14.05% |
| 2021 FY | 20.35 Billion JPY | 14.24% |
| 2021 Q4 | 5.31 Billion JPY | 13.58% |
| 2021 Q3 | 4.68 Billion JPY | -15.03% |
| 2021 Q2 | 5.5 Billion JPY | 13.7% |
| 2021 Q1 | 4.84 Billion JPY | -2.45% |
| 2020 Q2 | 4.48 Billion JPY | 10.05% |
| 2020 Q1 | 4.07 Billion JPY | -17.34% |
| 2020 FY | 17.81 Billion JPY | 11.11% |
| 2020 Q4 | 4.96 Billion JPY | 15.79% |
| 2020 Q3 | 4.28 Billion JPY | -4.33% |
| 2019 Q2 | 4.47 Billion JPY | 55.46% |
| 2019 Q4 | 4.92 Billion JPY | 31.69% |
| 2019 Q3 | 3.74 Billion JPY | -16.44% |
| 2019 FY | 16.03 Billion JPY | 5.45% |
| 2019 Q1 | 2.88 Billion JPY | -40.48% |
| 2018 Q3 | 3.62 Billion JPY | 1.24% |
| 2018 Q1 | 3.16 Billion JPY | -27.01% |
| 2018 FY | 15.2 Billion JPY | 2.57% |
| 2018 Q4 | 4.84 Billion JPY | 33.61% |
| 2018 Q2 | 3.57 Billion JPY | 13.23% |
| 2017 FY | 14.82 Billion JPY | -2.04% |
| 2017 Q4 | 4.33 Billion JPY | 0.0% |
| 2017 Q3 | - JPY | 0.0% |
| 2016 FY | 15.13 Billion JPY | -0.63% |
| 2015 FY | 15.22 Billion JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 62.14 Billion JPY | 64.384% |
| Takeda Pharmaceutical Company Limited | 4263.76 Billion JPY | 99.481% |
| Sumitomo Pharma Co., Ltd. | 314.55 Billion JPY | 92.963% |
| Shionogi & Co., Ltd. | 435.08 Billion JPY | 94.913% |
| Wakamoto Pharmaceutical Co.,Ltd. | 7.73 Billion JPY | -186.029% |
| Nippon Shinyaku Co., Ltd. | 148.25 Billion JPY | 85.07% |
| Kaken Pharmaceutical Co., Ltd. | 72.04 Billion JPY | 69.277% |
| Eisai Co., Ltd. | 741.75 Billion JPY | 97.016% |
| Morishita Jintan Co., Ltd. | 12.4 Billion JPY | -78.415% |
| Hisamitsu Pharmaceutical Co., Inc. | 141.7 Billion JPY | 84.38% |
| Mochida Pharmaceutical Co., Ltd. | 102.88 Billion JPY | 78.487% |
| Fuso Pharmaceutical Industries,Ltd. | 55.4 Billion JPY | 60.051% |
| Nippon Chemiphar Co., Ltd. | 30.74 Billion JPY | 28.014% |
| Tsumura & Co. | 150.84 Billion JPY | 85.327% |
| Kissei Pharmaceutical Co., Ltd. | 75.57 Billion JPY | 70.714% |
| Torii Pharmaceutical Co., Ltd. | 54.63 Billion JPY | 59.489% |
| Towa Pharmaceutical Co., Ltd. | 227.93 Billion JPY | 90.289% |
| Fuji Pharma Co., Ltd. | 40.88 Billion JPY | 45.868% |
| Zeria Pharmaceutical Co., Ltd. | 75.72 Billion JPY | 70.77% |
| KYORIN Holdings, Inc. | 119.53 Billion JPY | 81.483% |
| Taiko Pharmaceutical Co.,Ltd. | 5.04 Billion JPY | -339.17% |
| Daito Pharmaceutical Co.,Ltd. | 46.89 Billion JPY | 52.801% |
| SymBio Pharmaceuticals Limited | 5.58 Billion JPY | -295.98% |
| MedRx Co., Ltd | 26 Million JPY | -85031.327% |
| Mizuho Medy Co.,Ltd. | 10.98 Billion JPY | -101.407% |
| Solasia Pharma K.K. | 617 Million JPY | -3487.382% |
| Modalis Therapeutics Corporation | - JPY | -Infinity% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 62.84 Billion JPY | 64.779% |
| Sawai Group Holdings Co., Ltd. | 176.86 Billion JPY | 87.485% |
| Cyfuse Biomedical K.K. | 61.11 Million JPY | -36118.983% |
| Toho Holdings Co., Ltd. | 1476.71 Billion JPY | 98.501% |